. Author manuscript; available in PMC: 2009 Nov 2.

Published in final edited form as: Neuropsychopharmacology. 2006 Oct 25;32(2):471–482. doi: 10.1038/sj.npp.1301234

Table 1.

Summary of Subject Groups

	A9 calbindin		A9 parvalbumin		A47 calbindin		A47 parvalbumin

Variables	Control	MDD	Control	MDD	Control	MDD	Control	MDD
Age/years (mean±SD)	49.1±17.9	55.7±18.3	49.1±17.9	56.5±18.8	41.2±12.7	48.9±11.7	49.1±17.9	55.7±18.3
Gender	8M, 3F	8M, 6F	8M, 3F	7M, 6F	2M, 6F	4M, 6F	8M, 3F	8M, 6F
Suicide/nonsuicide	11N	9S, 5N	11N	8S, 5N	8N	4S, 6N	11N	9S, 5N
PMI/h (mean±SD)	19.4±5.8	21.6±4.8	19.4±5.8	21±4.5	17.6±7.6	22.6±3.7	19.4±5.8	21.6±4.8
TF/months (mean±SD)	23.8±15.7	10.97±3.9	23.8±15.7	10.7±3.9	25.4±13.4	18.7±14.7	28.8±19.8	15.8±13.3
Time in ethanol/months (mean±SD)	35.1±22.8	46.2±27.5	64.9±17.7	75.3±11.7	43.7±25.2	56.6±18.6	72.7±13.4	75.2±17.7
pH (mean±SD)	6.73±0.19	6.53±0.26	6.73±0.19	6.5±0.25	6.82±0.14	6.49±0.24	6.73±0.19	6.53±0.26